The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse, said Chun-Su Yuan, MD, PhD, the Cyrus Tang Professor of Anesthesia and Critical Care at the University of Chicago
Pros: Proven to reduce major heart risks
Removing GLP-1s from Rhode Islands Medicaid formulary for weight loss would save $6.3 million in general revenue, according to McKees proposed budget introduced on Jan
This story was originally published by the Rhode Island Current.
1 2 3 4 "GLP-1 drugs are transforming diabetes, obesity and more
These changes give semaglutide a long half-life of about 160h , and it only needs to be injected once a week for glucose control